Mirion enhances nuclear industry engagement with NEI and ANS memberships

ATLANTA - Mirion Technologies, Inc. (NYSE: MIR), a global provider of radiation safety solutions with a market capitalization of $3.06 billion, has joined the Nuclear Energy Institute (NEI) and enhanced its membership with the American Nuclear Society (ANS) by becoming a Trustee of Nuclear. InvestingPro data shows the company has demonstrated strong growth with revenue increasing 7.48% in the last twelve months. This move aligns Mirion with two leading nuclear organizations in the United States, enabling the company to participate in policy discussions and collaborate with industry experts.

The NEI acts as the nuclear energy industry’s policy organization in the U.S., advocating industry interests before legislative and regulatory bodies. As a member, Mirion will engage in policy discussions that influence the nuclear sector and support nuclear energy growth initiatives.

ANS, recognized as a premier international professional organization in the nuclear field, comprises professionals dedicated to the peaceful applications of nuclear science and technology. Mirion’s elevated role as an ANS Trustee of Nuclear places it on the leadership council, furthering its involvement in the industry’s development.

Mirion CEO Thomas Logan expressed enthusiasm about the memberships, emphasizing Mirion’s unique position in the nuclear landscape and its commitment to advancing the industry through collaboration with top experts and organizations. The company looks forward to contributing to innovative solutions and best practices that will define the future of nuclear energy.

Based in Atlanta, Georgia, Mirion employs approximately 2,800 people and operates in 12 countries. The company is focused on empowering innovations in radiation safety and medicine, supporting advancements in nuclear energy, and improving patient outcomes in cancer care with its range of solutions. InvestingPro analysis reveals strong fundamentals with a healthy current ratio of 2.26 and impressive gross profit margins of 46.68%. Two key InvestingPro Tips indicate that while the company wasn’t profitable in the last twelve months, analysts expect profitability this year. Subscribers can access 5 additional exclusive ProTips and comprehensive analysis through the Pro Research Report.

This strategic alignment with NEI and ANS is based on a press release statement and reflects Mirion’s ongoing efforts to drive progress and safety in the nuclear industry through its expertise and technology. The company’s stock has shown strong momentum, gaining over 44% in the past six months. For detailed financial analysis and expert insights on Mirion’s growth trajectory, investors can access the comprehensive Pro Research Report available on InvestingPro.

In other recent news, Mirion Technologies reported its fourth-quarter 2024 earnings, exceeding Wall Street expectations with an adjusted EPS of $0.17, compared to the forecasted $0.14. The company also reported higher-than-expected revenue, reaching $254.3 million against a forecast of $244.99 million. This strong performance was attributed to robust margins in the Nuclear & Safety segment, which helped offset a weaker showing in the Medical segment. Mirion Technologies’ orders in the Nuclear Power sector, which account for a significant portion of its revenue, grew by 8% year-over-year.

The company confirmed its adjusted EBITDA guidance for fiscal year 2025 to be between $215 million and $230 million and introduced an earnings per share (EPS) guidance of $0.45 to $0.50. Goldman Sachs maintained a Buy rating on Mirion Technologies with a price target of $21, reflecting optimism about the company’s long-term prospects, especially in the Nuclear sector. Mirion Technologies experienced a 7% year-over-year increase in total company organic orders, indicating a positive trend despite a high base of comparison from the previous year.

The company’s full-year revenue was $860.8 million, marking a 7.5% increase from the previous year, driven by strategic alliances and product innovations. Mirion Technologies’ EBITDA margins expanded by 90 basis points year-over-year in the fourth quarter, primarily due to improved procurement and operating leverage. The company also anticipates further revenue and margin expansion in 2025, supported by strong demand in the nuclear sector and strategic partnerships, including one with Siemens Healthineers.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.